In adult women, the medicine is used to cause the release of an egg from the ovary (ovulation) in women who are not ovulating and have not responded to treatment with the active ingredient “clomiphene citrate”.To work together with another active ingredient called “lutropin alfa” (“luteinizing hormone” or LH) to cause the release of an egg from the ovary (ovulation) in women whose bodies produce very few gonadotropins (FSH and LH).To trigger the development of multiple follicles (egg follicles, each containing an egg) in women undergoing assisted reproduction techniques (procedures that can help you become pregnant), such as “in vitro fertilization”, “intratubal gamete transfer”. ” or “Intratubal zygote transfer”.
OVALEAP 300 I.U./0.5 ml Cyl.Amp.+ 10 Pen Inj.Nad.,1 piece
€273.40
The medicine contains the active ingredient “follitropin alfa”. Follitropin alfa is a “follicle-stimulating hormone” (FSH) and belongs to the group of hormones called “gonadotropins”.
SKU:
Deprescmed88
Categories: Gynecology, Medicines
Description
Additional information
Weight | 0.10 kg |
---|---|
Producing country | |
Manufacturer |
Orifarm GmbH |
Dosage form | |
Usage | |
EAN |
AP-12568958 |
Shipping & Delivery